-
Stimulus bill packs a windfall for FDA and COVID-19 drug developers — Roche nixes Tecentriq bladder cancer accelerated approval — AI uncovers Lilly's Olumiant as potential Alzheimer's treatment See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new pageDismiss Notice
Osteocell/XLIF Clinical Trial results out yet?
Discussion in 'NuVasive' started by Anonymous, Oct 29, 2012 at 9:12 AM.